.Pharmacolibrary.Drugs.D_Dermatologicals.D07X_CorticosteroidsOtherCombinations.D07XA02_Prednisolone.Prednisolone .Pharmacolibrary.Drugs.D_Dermatologicals.D07X_CorticosteroidsOtherCombinations.D07XA02_Prednisolone.Prednisolone| name: | Prednisolone |
| ATC code: | D07XA02 | route: | oral |
| n-compartments | 2 |
Prednisolone is a synthetic glucocorticoid used as an anti-inflammatory and immunosuppressive agent. It is widely prescribed for a range of conditions including autoimmune diseases, allergic reactions, asthma, rheumatoid arthritis, and various skin disorders. It is approved and in current clinical use globally.
Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.
de Truchis, C, et al., & Boyer, O (2023). Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant. British journal of clinical pharmacology 89(5) 1532–1540. DOI:10.1111/bcp.15610 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36510685
Petersen, KB, et al., & Schmiegelow, K (2003). Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 51(6) 465–473. DOI:10.1007/s00280-003-0602-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12698270
Yoshida, K, et al., & Chanu, P (2021). Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients. Journal of clinical pharmacology 61(12) 1579–1591. DOI:10.1002/jcph.1942 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34273118